Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Long-Term Deferred Tax (2018 - 2024)

OptimizeRx's Long-Term Deferred Tax history spans 7 years, with the latest figure at $4.5 million for Q4 2024.

  • For Q4 2024, Long-Term Deferred Tax rose 3.55% year-over-year to $4.5 million; the TTM value through Dec 2024 reached $4.5 million, up 3.55%, while the annual FY2024 figure was $4.5 million, 3.55% up from the prior year.
  • Long-Term Deferred Tax for Q4 2024 was $4.5 million at OptimizeRx, up from $4.3 million in the prior quarter.
  • Across five years, Long-Term Deferred Tax topped out at $10.5 million in Q4 2022 and bottomed at $4.3 million in Q4 2023.
  • The 5-year median for Long-Term Deferred Tax is $4.5 million (2020), against an average of $6.4 million.
  • The largest annual shift saw Long-Term Deferred Tax surged 73.31% in 2021 before it plummeted 58.66% in 2023.
  • A 5-year view of Long-Term Deferred Tax shows it stood at $4.5 million in 2020, then soared by 73.31% to $7.9 million in 2021, then skyrocketed by 33.11% to $10.5 million in 2022, then tumbled by 58.66% to $4.3 million in 2023, then grew by 3.55% to $4.5 million in 2024.
  • Per Business Quant, the three most recent readings for OPRX's Long-Term Deferred Tax are $4.5 million (Q4 2024), $4.3 million (Q4 2023), and $10.5 million (Q4 2022).